143 related articles for article (PubMed ID: 9575571)
1. The molecular basis for therapeutic concepts utilizing CD14.
Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
[TBL] [Abstract][Full Text] [Related]
3. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation.
Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ
Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
[TBL] [Abstract][Full Text] [Related]
5. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation.
Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR
J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845
[TBL] [Abstract][Full Text] [Related]
6. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.
Vita N; Lefort S; Sozzani P; Reeb R; Richards S; Borysiewicz LK; Ferrara P; Labéta MO
J Immunol; 1997 Apr; 158(7):3457-62. PubMed ID: 9120307
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide.
Stelter F; Loppnow H; Menzel R; Grunwald U; Bernheiden M; Jack RS; Ulmer AJ; Schütt C
J Immunol; 1999 Dec; 163(11):6035-44. PubMed ID: 10570291
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.
Hailman E; Vasselon T; Kelley M; Busse LA; Hu MC; Lichenstein HS; Detmers PA; Wright SD
J Immunol; 1996 Jun; 156(11):4384-90. PubMed ID: 8666811
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
11. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14.
Su GL; Goyert SM; Fan MH; Aminlari A; Gong KQ; Klein RD; Myc A; Alarcon WH; Steinstraesser L; Remick DG; Wang SC
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G640-5. PubMed ID: 12181178
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
13. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction.
Delude RL; Yoshimura A; Ingalls RR; Golenbock DT
J Immunol; 1998 Sep; 161(6):3001-9. PubMed ID: 9743364
[TBL] [Abstract][Full Text] [Related]
14. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria.
Jack RS; Grunwald U; Stelter F; Workalemahu G; Schütt C
Eur J Immunol; 1995 May; 25(5):1436-41. PubMed ID: 7539760
[TBL] [Abstract][Full Text] [Related]
15. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.
Yu B; Wright SD
J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357
[TBL] [Abstract][Full Text] [Related]
16. Moesin: a potential LPS receptor on human monocytes.
Amar S; Oyaisu K; Li L; Van Dyke T
J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions.
Pollack M; Ohl CA; Golenbock DT; Di Padova F; Wahl LM; Koles NL; Guelde G; Monks BG
J Immunol; 1997 Oct; 159(7):3519-30. PubMed ID: 9317151
[TBL] [Abstract][Full Text] [Related]
18. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system.
Savedra R; Delude RL; Ingalls RR; Fenton MJ; Golenbock DT
J Immunol; 1996 Sep; 157(6):2549-54. PubMed ID: 8805656
[TBL] [Abstract][Full Text] [Related]
20. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
